Clinical trial
MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast…
NCT00223548 · University of Ulm, Other · Completed
Key facts
| NCT number | NCT00223548 |
|---|---|
| Title | MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application |
| Official title | MESNA Zur Prophylaxe Der Kontrastmittel-Induzierten Nephropathie |
| Lead sponsor | University of Ulm, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Renal Insufficiency, Serum Creatinine Concentration, Contrast Media Exposition |
| Intervention type | Drug |
| Interventions | sodium 2-mercaptoethane sulfonate |
| Enrollment | 106 |
| Start date | Oct 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: